期刊文献+

食管癌中Caveolin-1与P53的表达及临床意义 被引量:9

Expressions of Caveolin-1 and P53 in esophageal carcinoma and its clinical significance
在线阅读 下载PDF
导出
摘要 目的探讨Caveolin-1与P53在食管鳞癌组织中的表达及其临床意义。方法应用组织芯片技术结合免疫组化检测63例食管鳞癌组织,20例食管鳞状上皮非典型增生及15例正常食管鳞状上皮中Caveolin-1与P53蛋白的表达。结果食管癌中Caveolin-1与P53的表达高于正常食管黏膜、非典型增生食管黏膜(P<0.05);Caveolin-1的表达与淋巴结转移、病理学分级及临床分期有关,而与患者的年龄、性别、肿瘤的大小、浸润深度无关(P>0.05);P53的表达与淋巴结转移、浸润深度有关,而与患者的年龄、性别、肿瘤的大小、病理分级及临床分期无关(P>0.05)。Spearm an等级相关分析显示Caveolin-1与P53表达呈正相关(r=0.519,P=0.000)。结论 Caveolin-1与P53过表达可能是食道癌发生、发展以及浸润转移的重要原因之一,Caveolin-1可能上调P53的活性,联合检测可判断食管癌的预后。 Objective To study the expression of Caveolin-1 and P53 proteins in esophageal squamous cell carcinoma and its clinical significance.MethodsWe tested Caveolin-1 and P53 proteins by immunohistochemistry and tissue microarray in 63 cases of esophageal squamous cell carcinoma,20 cases of atypical hyperplasia and 15 cases of normal esophageal squamous cell.ResultsThe expressions of Caveolin-1 and P53 was significantly higher in esophageal carcinoma than in normal esophageal mucosa,and esophageal dysplasia(P〈0.05);Caveolin-1 expression and lymph node metastasis,pathological grade and clinical stage,but not with age,gender,tumor size,invasive depth independent(P〉0.05).P53 expression and lymph node metastasis,depth of invasion,but not with patient age,gender,tumor size,pathological grade and clinical stage(P〉0.05).Spearman rank correlation analysis showed that the expression of Caveolin-1 was positively correlated with P53(r=0.519,P=0.000).ConclusionCaveolin-1 and P53 overexpression may be the occurrence of esophageal cancer,development and metastasis is one of the important reasons,and the Caveolin-1 may increase the activity of P53.The joint test can determine the prognosis of esophageal cancer.
出处 《中外医学研究》 2011年第14期7-10,共4页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 食管癌 组织芯片 CAVEOLIN-1 P53 免疫组织化学 Esophageal carcinoma Tissue microarray Caveolin-1 P53 Immunohistochemistry
  • 相关文献

参考文献15

  • 1Rothberg KG,Heuser JE,Donzell WC,et al.Caveolin,a protein component of caveolae membrane coats.Cell,1992,68(4):673-682.
  • 2潘晓琳,高志斌,陆天才,李洪安,郑兴征.卵巢癌中k-ras基因点突变及p53蛋白表达[J].临床与实验病理学杂志,2005,21(1):66-69. 被引量:15
  • 3漆楚波,朱润庆,夏和顺,王明伟.组织芯片简易制作方法及免疫组化有效性分析[J].肿瘤防治研究,2007,34(8):629-632. 被引量:17
  • 4Galbiati F,Volonte D,Engelman JA,et al.Targeted downregulation of caveolin-1 is sufficient to drive transformation and hyperactivate the p42/44 MAP kinase cascade.EMBO J,1998,17(22):6633-6648.
  • 5Bender FC,Reymond MA,Bron C,et al.Caveolin-1 levels are down-regulated in human colon tumors,and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity.Cancer Res,2000,6(20):5870-5878.
  • 6于涓瀚,韦强,齐凤杰,徐洪涛,王恩华.窖蛋白-1在肺癌中的表达及意义[J].中华病理学杂志,2006,35(11):664-668. 被引量:19
  • 7汪翼,罗红梅,杨罗艳.Caveolin-1的表达及其与膀胱癌病理分级及临床分期的关系[J].中国医师杂志,2005,7(6):780-782. 被引量:6
  • 8Fong A,Garcia E,Gwynn L,et al.Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation.Am J Clin Pathol,2003,120(1):93-100.
  • 9Ando T,Ishiguro H,Kimura M,et al.The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.Oncol Rep,2007,18(3):601-609.
  • 10Kato K,Hida Y,Miyamoto M,et al.Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and Pathologic stage.Cancer,2002,94(4):929-933.

二级参考文献57

  • 1高雪,孙媛,黄磊,陈晓燕,张开立,孔庆友,刘佳,李宏.Caveolin-1在胃癌组织中的表达及临床生物学意义[J].癌症,2005,24(3):311-316. 被引量:22
  • 2蒋时红,刘旺根,王雪萍,张桂兰.组织芯片手工制作工具[J].解剖学杂志,2006,29(2):145-145. 被引量:7
  • 3吴小华,蔡树模,张志毅,施达仁,陆洪芬.卵巢肿瘤中癌基因 nm23Hl,c-erbB-2,ras 和 p53 的蛋白表达与腹膜后淋巴结转移关系的研究[J].肿瘤,1997,17(3):134-136. 被引量:5
  • 4Jiang W,Kahn SM,Guillem JG,et al. Rapid detection of ras oncogenes in human tumors: applications to colon,esophageal,and gastric cancer[J]. Oncogene,1989,4(7): 923-8.
  • 5Yanagisawa A,Ohtake K,Ohashi K, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation[J]. Cancer Res,1993,53(5): 953-6.
  • 6Fujita M,Enomoto T,Murata Y. Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes[J]. Mol Cell Endocrinol,2003,202(1-2):97-9.
  • 7Mandai M,Konoshi I,Kuroda H,et al. Heterogeneous distribution of k-ras mutated epithelia in mucinous ovarian tumors with special reference to histopathology[J]. Hum Pathol,1998,29(1):34-40.
  • 8Pellegata NS,Sessa F,Renault B,et al. k-ras and p53 gene mutation in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions[J]. Cancer Res,1994,54(6):1556-60.
  • 9Maeshima A,Miyagi A,Hirai T,et al. Mucin-producing adenocarcinoma of the lung,with special reference to goblet cell type adenocarcinoma: immunohistochemical observation and Ki-ras gene mutation[J]. Pathol Int,1997,47(7):454-60.
  • 10Cuatrecasas M,Matias-Guiu X,Prat J. Synchronous mucinous tumors of the appendix and the ovary associated with psuedomyxoma peritonei[J]. Am J Surg Pathol,1996,20(6):739-46.

共引文献54

同被引文献97

引证文献9

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部